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RNA binding proteins of the conserved CUGBP1, Elav-like factor (CELF) family contribute to heart and skeletal muscle de-
velopment and are implicated in myotonic dystrophy (DM). To understand their genome-wide functions, we analyzed the
transcriptome dynamics following induction of CELF1 or CELF2 in adult mouse heart and of CELF1 in muscle by RNA-seq,
complemented by crosslinking/immunoprecipitation-sequencing (CLIP-seq) analysis of mouse cells and tissues to distin-
guish direct from indirect regulatory targets. We identified hundreds of mRNAs bound in their 3′ UTRs by both CELF1
and the developmentally induced MBNL1 protein, a threefold greater overlap in target messages than expected, including
messages involved in development and cell differentiation. The extent of 3′ UTR binding by CELF1 andMBNL1 predicted the
degree of mRNA repression or stabilization, respectively, following CELF1 induction. However, CELF1’s RNA binding spe-
cificity in vitro was not detectably altered by coincubation with recombinant MBNL1. These findings support a model in
which CELF and MBNL proteins bind independently to mRNAs but functionally compete to specify down-regulation or
localization/stabilization, respectively, of hundreds of mRNA targets. Expression of many alternative 3′ UTR isoforms
was altered following CELF1 induction, with 3′ UTR binding associated with down-regulation of isoforms and genes. The
splicing of hundreds of alternative exons was oppositely regulated by these proteins, confirming an additional layer of reg-
ulatory antagonism previously observed in a handful of cases. The regulatory relationships between CELFs and MBNLs in
control of both mRNA abundance and splicing appear to have evolved to enhance developmental transitions in major clas-
ses of heart and muscle genes.
[Supplemental material is available for this article.]
CELF RNA binding proteins (RBPs) play roles in early embryonic
development, heart, and skeletal muscle functions. They are also
thought to contribute to DM pathogenesis (Timchenko et al.
1996) and have been suggested to contribute to other diseases
(Ladd 2013). The six family members present in mammals can
be divided into two subfamilies: CELF1-2, which are expressed
most highly in heart, skeletal muscle, and brain, and CELF3-6,
which exhibit more restricted expression (Dasgupta and Ladd
2012). The CELF proteins contain two N-terminal RNA recogni-
tion motifs (RRMs) and one C-terminal RRM, with which they
bind GU-rich RNAs, and a linker region termed the “divergent
domain” that separates RRM2 and RRM3 and is involved in the
regulation of alternative pre-mRNA splicing and mRNA decay
(Han and Cooper 2005; Vlasova et al. 2008).
During normal development, CELF1 and CELF2 proteins are
highly expressed in early embryonic stages and are then down-reg-
ulated more than 10-fold in skeletal muscle (Ladd et al. 2005) and
the heart (Kalsotra et al. 2008) during post-natal development, re-
maining at low levels in adult tissues. This developmental down-
regulation occurs throughmultiplemechanisms, including repres-
sion bymicroRNAs (miRNAs) and reductions in protein phosphor-
ylation, which destabilizes the protein (Kalsotra et al. 2010, 2014).
However, in DM type 1 (DM1), CELF1 protein levels increase in
skeletal muscle and heart (Timchenko et al. 2004) as the protein is
stabilized by PKC-mediated phosphorylation (Kuyumcu-Martinez
et al. 2007).
The combination of increased CELF levels and MBNL seques-
tration by CUG repeat RNA is thought to be responsible for
much of DM pathology by reversing the developmental changes
in both proteins toward embryonic levels, shifting splicing of reg-
ulatory targets toward fetal isoforms (Philips et al. 1998; Ho et al.
2004; Lin et al. 2006; Kuyumcu-Martinez et al. 2007). Expression
of CELF1 in adult mice recapitulates a subset of the misregulated
splicing events observed in DM1 skeletal muscle and heart (Kalso-
tra et al. 2008, 2010; Ward et al. 2010). Of 44 developmentally
regulated alternative splicing events in heart development that
were investigated, 24 were found to revert toward embryonic
splicing levels in response to inducible expression of CELF1 in
the adult heart or in mice lacking Mbnl1 (Kalsotra et al. 2008). A
long-standing question has been whether CELF and MBNL splic-
ing factors share regulatory targets and whether they synergizePresent addresses: 6Department of Biological Sciences, 7Columbia
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or antagonize. The half-dozen events known to be regulated by
both CELF and MBNL proteins, including H2afy exon 6 and
Mbnl2 exon 8, are regulated antagonistically (Ho et al. 2005;
Dhaenens et al. 2008; Kalsotra et al. 2008). However, in a study an-
alyzing CELF motifs present near Mbnl-responsive alternative ex-
ons, evidence for widespread antagonistic regulation was not
observed (Du et al. 2010).
CELF proteins are present in both cytoplasm and nucleus and
play roles in deadenylation, RNA stability, and translation, as well
as splicing (Paillard et al. 2003; Timchenko et al. 2004; Vlasova
et al. 2008). Tethering CELF1 to an mRNA is sufficient for destabi-
lization of themRNA (Barreau et al. 2006), and addition ofGU-rich
sequences to anRNA confers destabilization followingCELF1 over-
expression (Masuda et al. 2012). Human CELF1 is 88% identical
to the Xenopus homolog embryo deadenylation element binding
protein (EDEN-BP) and can functionally replace it, binding to
the EDEN element to control poly(A) tail length and aiding in rap-
id deadenylation of maternal mRNAs after fertilization (Paillard
et al. 2003). CELF1 interacts with poly(A)-specific ribonuclease
(PARN) in HeLa cell extracts to promote deadenylation of FOS
and TNF transcripts (Moraes et al. 2006). Furthermore, siRNA-me-
diated knockdown ofCELF1 in HeLa cells andmyoblasts led to the
stabilization of a set of normally rapidly degraded transcripts
bound by CELF at GU-rich elements (GREs) and GU-repeats
(Vlasova et al. 2008; Ji et al. 2009; Lee et al. 2010; Rattenbacher
et al. 2010). It is possible that abnormal up-regulation of CELF pro-
teins in adult tissues in DM1 could impact the stability of many
transcripts and contribute to DM pathology.
To investigate the functional significance of the post-natal
down-regulation of CELF in heart and skeletal muscle tissues, we
inducibly expressed CELF1 in adult mouse heart or muscle or
CELF2 in adult heart and performed a time-series RNA-seq analysis
following induction, complemented by high-throughput bio-
chemical assays and comparisons to available data for MBNL1.
Our observations lead to a model in which CELF and MBNL pro-
teins compete to specify different mRNA fates so as to change
the expression and localization of hundreds of mRNAs during
development.
Results
Identification of hundreds of CELF-responsive exons
We performed strand-specific paired-end RNA sequencing (RNA-
seq) of poly(A)+ RNA from skeletal muscle or heart of mice in
which CELF1 was induced, or heart of mice in which CELF2 was
induced at several time points post-induction, and from control
mice, in biological triplicate. The CELF1mice have been described
previously (Koshelev et al. 2010; Ward et al. 2010). The CELF2
mouse model was newly developed here and is described in
Methods. All mice used are summarized in Supplemental Table
S1. Human CELF1 or CELF2 transgenes were induced in mice by
administration of doxycycline, in separatemouse lines for each tis-
sue/protein pair, and reached levels between five- and 10-fold
above endogenous levels (Supplemental Fig. S1A,B). The level of
CELF1 mRNA increased strongly before declining at the end of
the time course, likely as a secondary effect of heart pathology
on the Myh1 promoter that drives rtTA (Lowes et al. 1997).
However, CELF1 protein levels consistently increased in these
mice at least eightfold in skeletal muscle (Ward et al. 2010) and ap-
proximately fourfold in heart and remained high through at least
day 7 (Koshelev et al. 2010). Heart pathology was not observed in
the CELF2 mouse, and mRNA and protein levels increased
throughout the time course (Supplemental Fig. S1C,F). RNA was
isolated from three Tet-inducible mice each at 12, 24, and 72 h
and 7 d following induction and from three control mice lacking
Tet-inducible CELF1 or CELF2 transgenes, treated with doxycy-
cline for 72 h. The MISO software for statistical inference of splic-
ing changes using RNA-seq data (Katz et al. 2010) was used to
estimate a percentage spliced in (PSI, or Ψ) value for each cassette
(skipped) exon, which estimates the fraction of a gene’s messages
that include the exon.We also calculatedΨ values for alternative 5′
and 3′ splice sites and retained introns. For each comparison of Ψ
between samples, we calculated a Bayes factor (BF) representing
the ratio of the likelihood of the hypothesis that Ψ values differ
from the null hypothesis of no change in Ψ, and we used BFs to
identify differentially regulated exons.
We identified thousands of exons whose Ψ values changed
between time points at a BF cutoff of five, a value supported by pre-
vious studies of RBPs (Katz et al. 2010). For example, exon 3 in
Tmed2 had a Ψ of 79% in the control heart but decreased to 13%
after CELF1 induction for 7 d (Fig. 1A). To identify splicing events
that change monotonically over time, we developed a permuta-
tion-based method that could be applied to time course data. We
ordered samples chronologically, and for each event compared
all pairs of samples fromdifferent time points, tallying the number
of comparisons representing a significant increase or significant
decrease in Ψ (at BF > 5). We calculated a quantity called δ, the
number of significant positive ΔΨ values (increases over time) mi-
nus the number of significant negative ΔΨ values (Supplemental
Fig. S2A). To assess statistical significance, we recalculated δ after
randomly permuting the sample labels. Repeating this process
100 times, we generated a null distribution and derived a “mono-
tonicity Z-score” (MZ) defined as MZ = (δ− μ)/σ, where μ and σ are
the mean and standard deviation of the null distribution of δ val-
ues, respectively. Large positive or negative MZ values indicate
consistent increase or decrease, respectively, in the inclusion of
an alternative exon over the time course. (MZ scores and Ψ values
of alternative exons for all experiments are listed in Supplemental
Table S2.) We observed 627 and 825 exons responsive to CELF1
induction at a MZ score of 1.8 in heart and skeletal muscle,
respectively.
About 30% of splicing changes in heart development
respond to CELF1 induction
We next sought to understand the functions of CELF proteins in
different tissues and developmental stages. By comparing ΔΨ val-
ues of monotonically changing (high MZ) skipped exons between
CELF1-induced heart and CELF1-induced skeletal muscle, we ob-
served a high correlation (RSpearman = 0.64), suggesting that the
functions and regulatory targets of CELF1 in these tissues are quite
similar (Fig. 1B). To ask about functions of different CELF family
members, we compared splicing changes in the heart following in-
duction of CELF1 or CELF2. This comparison yielded a moderate
positive correlation (RSp = 0.47), suggesting similar but not neces-
sarily identical splicing functions (Fig. 1C).
To explore connections to the developmental roles of CELF
proteins, we compared splicing in the CELF1 heart to changes
that occur during normal heart development. Developmental
changes were analyzed by use of an RNA-seq time series (Giudice
et al. 2014), including embryonic day 17 (E17), post-natal (PN)
day 1, PN 10, PN 28, and adult, during which CELF1 protein levels
fall by more than 10-fold (Kalsotra et al. 2008). In all, 234
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2 Genome Research
www.genome.org
 Cold Spring Harbor Laboratory Press on May 21, 2015 - Published by genome.cshlp.orgDownloaded from 
Figure 1. CELF1 and CELF2 regulate hundreds of splicing events, reversing many changes during heart development and antagonizing a subset ofMbnl-
regulated exons. (A) RNA-seq read coverage across Tmed2 exon 3 from mouse heart at several time points following CELF1 induction. MISO Ψ values and
95% confidence intervals shown at right. (B) Splicing changes that occur following CELF1 overexpression (OE) in heart correlate with splicing changes that
occur following CELF1 overexpression in muscle. n = 2496 alternative splicing events (skipped exons, alternative 3′ splice sites, alternative 5′ splice sites,
retained introns, and mutually exclusive exons) shown: Monotonically changing exons shown as black circles, others as gray dots. Correlation values of
monotonic events (shown) are higher than for all events: The numbers of monotonic events in each quadrant are shown in corners. (C) Splicing changes
that occur in response to CELF1 overexpression in heart correlate with splicing changes that occur in response to CELF2 overexpression in heart. As in B, with
n = 2129 skipped exons shown. (D) Splicing changes that occur in response to CELF1 overexpression in heart inversely correlate with splicing changes that
occur duringmouse heart development. As in B, with n = 1952 skipped exons shown. (E) Splicing changes that occur inMbnl1 KO heart inversely correlate
with splicing changes that occur during mouse heart development. n = 3190 skipped exons shown, as in B. (F ) Splicing changes that occur in Mbnl1 KO
muscle correlate with splicing changes that occur following CELF1 overexpression in muscle. n = 1501 skipped exons shown. Events that changed mono-
tonically, or with BF > 5, following CELF1 overexpression in muscle orMbnl1 KO in muscle, respectively, are shown in black, and correlations are listed for
these events. Events that also changedmonotonically during heart development are shown in red. (G) Exons regulated during heart development also tend
to change in Mbnl1 andMbnl2 knockdown myoblasts, in Mbnl1 and Mbnl2 knockout mice, and in CELF1 or CELF2 overexpressing mice. Enrichment (ob-
served/expected number of regulated exons) is shown in the heatmap. (H) Splicing of exons regulated in response to CELF overexpression orMbnl depletion
tends to change in a direction opposite from changes that occur during heart development. The fraction of events changing in the same direction for each
pair of comparisons is shown in the heatmap (only biases significant at P < 0.01 by binomial test are colored). See also Supplemental Figures S1 and S2 and
Supplemental Tables S1–S4.
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alternatively skipped exons changed monotonically in heart de-
velopment and/or following CELF1 induction. Splicing of 198
(85%) of these exons changed in the opposite direction following
CELF1 induction from that during heart development, with a fair-
ly strong negative correlation (RSp =−0.59, Fig. 1D). Thus, CELF1
induction triggers widespread reversal of heart developmental
splicing and suggests that normal reductions in CELF activity dur-
ing heart development may contribute to a substantial portion—
perhaps 30% (Supplemental Fig. S2B)—of the splicing changes
that occur during normal heart development (Kalsotra et al.
2008; Giudice et al. 2014).
More than 200 exons are regulated antagonistically
by CELF and MBNL proteins
Sixmouse exons (Kalsotra et al. 2008) and at least one human exon
(Ho et al. 2004) are known to be regulated antagonistically by
CELF1 and MBNL1. Confirming and extending this trend, we
identified dozens of additional exons regulated by both factors.
Mbnl1 depletion (Wang et al. 2012) mimicked a reversal of many
splicing changes that occur during heart development (RSp =
−0.47) (Fig. 1E). In skeletal muscle, we detected 120 exons whose
splicing was responsive to both proteins, of which 78 (65%) were
regulated in an antagonistic fashion (Fig. 1F; for exons responsive
to both factors, see Supplemental Table S3). Extending this anal-
ysis to additional tissues and cell lines and comparing to heart
development, we found that exons responsive to induction of
CELF1 or CELF2 showed a strong and quite general tendency to
also respond to Mbnl1 depletion and to be developmentally regu-
lated (Fig. 1G). Furthermore, the direction of splicing regulation
tended to oppose normal developmental transitions, with both
Mbnl1 depletion and CELF1 induction often reversing develop-
mental changes (Fig. 1H; Supplemental Table S3).
The observed splicing antagonismmight result fromdirect ef-
fects of CELF1 on splicing or potentially from indirect effects on
MBNL expression by CELF proteins. We found that CELF1 induc-
tion in heart and muscle yielded only modest changes in the
mRNA levels of Mbnl1 (up 15% in heart, down 10% in muscle)
and Mbnl2 (up 9% in heart, down 12% in muscle) by RNA-seq
RPKM and did not change inclusion of Mbnl1 exon 5, which can
regulate nuclear-cytoplasmic distribution of MBNL1 (Supplemen-
tal Fig. S1D,E; Lin et al. 2006). Furthermore, CELF1 overexpression
in C2C12 mouse myoblasts did not detectably alter MBNL1 pro-
tein levels (Supplemental Fig. S1G) or change the localization of
MBNL1 byWestern blot (data not shown). Finally, inclusion levels
of exons bound and regulated by MBNL1, but not bound by
CELF1, showed no tendency to change in a direction consistent
with an overall decrease in MBNL1 activity (data not shown).
These observations indicate that antagonistic regulation of many
MBNL-dependent splicing events by CELF proteins results pre-
dominantly from direct effects on splicing rather than indirectly
through regulation of MBNL activity.
In total, 206 alternative exons were responsive to both
Mbnl1 depletion and CELF1 induction in muscle and/or heart.
These exonswere enriched for several GeneOntology (GO) catego-
ries, including “cell differentiation,” “multicellular organismal de-
velopment,” “microtubule cytoskeleton,” and “cell junction,”
suggesting roles in developmental remodeling of the heart (Sup-
plemental Table S4). Furthermore, 124 of these exons (60%)
preserved the translational reading frame (compared to a back-
ground of 44% of alternative exons, P < 0.001, binomial test), sug-
gesting that the splicing activities of CELF and MBNL proteins are
predominantly involved in shaping the spectrum of protein iso-
forms expressed in the heart. These observations provide ge-
nome-wide evidence for the principle that CELF and MBNL
proteins exert opposing effects on the splicing of a large cohort
of exons. They also expand the number of developmentally regu-
lated CELF-/MBNL-responsive exons several-fold.
Transcriptome-wide binding locations of CELF1 in heart,
muscle, and myoblasts
To identify transcript sites bound by CELF1, we performed CLIP-
seq analysis using the 3B1 mouse monoclonal antibody against
the endogenous CELF1 protein, yielding 1.6 million, 1.0 million,
and 1.6 million reads uniquely mapping to the genome and splice
junctions in 16-wk-old C57BL/6 heart, 16-wk-old C57BL/6 mus-
cle, and C2C12 myoblast samples, respectively, after collapsing
identical reads. Mapping occurred predominantly to transcribed
regions, with enrichment for introns and/or 3′ UTRs (Supplemen-
tal Fig. S3A), consistent with previous studies (Masuda et al. 2012).
CELF1 binding locations were consistently observed across
different tissues, for example, in the 3′ UTR of the myeloid-associ-
ated differentiation marker gene,Myadm (Fig. 2A). CELF1 binding
density along mRNAs, assessed in 5-nucleotide (nt) windows, was
highly correlated across tissues and cell lines and was distinct
from that observed for MBNL1 (Fig. 2B). Controlling for pre-
mRNA length and gene expression, CELF1 CLIP clusters were en-
riched for UGU-containing pentanucleotides (5mers) in the heart
and other tissues (Fig. 2C; Supplemental Fig. S3B). Introns flanking
alternative exons with CLIP clusters within 1 kb from either splice
site were more highly conserved across species, in particular in the
downstream intron, supporting their in vivo function (Fig. 2D).
To more precisely map sites of CELF1 binding, we measured
the frequency of “crosslink-induced substitutions” (CISs)—posi-
tions where CLIP-seq reads differ from the genome (Kishore et al.
2011; Wang et al. 2012)—at each position within CLIP clusters.
We noted that guanines with a high CIS showed biases in flanking
bases, with the −1 base preceding the substituted guanine increas-
ingly biased toward uracil as CIS frequency increased (reaching
∼61% in heart); the base at the +1 position was also biased toward
uracil (Fig. 2E; Supplemental Fig. S3C). The implied CIS-enriched
motif UGU resembles the motifs observed in Figure 2C and in
previous studies of CELF1 binding affinity (Marquis et al. 2006;
Lambert et al. 2014), suggesting that frequently substituted gua-
nines are highly enriched for sites of direct crosslinking to CELF1
protein.
Context-dependent regulation of splicing by CELF1
Exons whose splicing changed after CELF1 induction were en-
riched for CELF1 CLIP clusters (Supplemental Fig. S4). To deter-
mine an RNA map describing the splicing regulatory activity of
CELF1,we analyzed the locationofCELF1 clusters relative to exons
responsive to CELF1 overexpression in heart and/or muscle. We
found that cassette alternative exons bound by CELF1 were more
likely to be repressed followingCELF1 induction in heart andmus-
cle (Fig. 2F), with 80%–85% of exons with MZ score >1.5 being
repressed versus 15%–20% being activated. Though we had rea-
sonable statistical power, we did not observe a consistent trend to-
ward repression or activation of exons bound by CELF1 in the
upstream or downstream introns. These observations suggest
that exonic binding by CELF family members may directly repress
splicing, while the direction of splicing regulation resulting from
intronic binding may depend on other variables such as RNA
Wang et al.
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Figure 2. CELF1 binds to consistent locations across cells and tissues and represses splicing of bound exons. (A) CELF1 CLIP-seq read coverage across the
3′ UTR of the mouseMyadm gene. Binding locations are highly correlated between muscle and heart. (B) Correlation of CLIP tag densities in 5-nt windows
across all 3′ UTRs expressed in mouse heart, muscle, and myoblasts. (C) Histogram of enrichment Z-scores of 5mers based on frequency of occurrence in
CELF1 heart CLIP clusters relative to control regions from the 3′ UTRs. (D) Meta-exon analysis of conservation (mean + 95% confidence interval of
phastCons score in 5-nt windows shown) at a range of distances from 3′ and 5′ splice sites of exons with (red) and without (black) overlapping CELF1
CLIP clusters in heart. n = 432 skipped exons shown. (E) Information content (relative entropy compared to uniform) of genomic positions in regions where
CELF1 CLIP-seq reads map, grouped by the frequency of substitution in CLIP reads relative to genome of the central G position. (F ) Fraction of significantly
repressed exons (Ψ at 7 d <Ψ in control animals) with or without CLIP clusters, at three thresholds of monotonicity Z-score from CELF1 overexpression time
courses in heart and muscle. Significance was assessed by binomial test, where the number of events with CLIP clusters that were repressed was compared
to the fraction of events without CLIP clusters that were repressed. (G) Design of experiment involving splicing reporters and Pumilio-based synthetic splic-
ing factors, as well as assessment of splicing by qRT-PCR. (H) Tethering the divergent domain of CELF1 to a cassette exon in a splicing reporter by Pumilio
fusion promotes exon skipping. In a positive control, tethering of RS domains to the cassette exon enhances exon inclusion. Enhancement by RS and re-
pression by CELF1 occur only when the Pumilio domain has affinity for the inserted oligonucleotide. See also Supplemental Figures S3 and S4 and
Supplemental Table S5.
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structure or cooperation or antagonismwith other RBPs (Dembow-
ski and Grabowski 2009; Goo and Cooper 2009).
To directly test whether CELF1 could repress splicing when
bound to a cassette exon, we fused the C-terminal “divergent
domain” of CELF1 (omitting the RRMs) to two different Pumilio
(Puf) domains, each recognizing a distinct eight-base Puf motif,
as in Wang et al. (2009a). We expressed these constructs in HeLa
cells, along with a splicing reporter (Xiao et al. 2009) containing
either cognate or noncognate Puf motifs within the cassette
exon, and used quantitative RT-PCR to assess splicing changes
(Fig. 2G).We found that expression of CELF1-Puf fusion decreased
Ψ from∼25% to∼12%when pairedwith the cognate Pufmotif but
had a negligible effect when paired with the noncognate motif.
Thus, recruitment of a single CELF1 protein molecule to an exon
appears sufficient to reduce splicing by double-digit percentage
values in this system. Natural regulatory targets often have multi-
ple CELF1 binding sites; recruitment of multiple CELF1 proteins is
likely tomagnify the impact on splicing in themode of other splic-
ing regulatory factors (Matlin et al. 2005). Control RS domain-Puf
fusions activated splicing, as expected (Fig. 2H;Wang et al. 2009a).
These observations indicate that tethering the CELF1 divergent
domain to an exon is sufficient to repress its splicing.
Dose-dependent down-regulation of expression associated
with CELF1 binding to 3′ UTRs
We observed extensive CELF1 binding to 3′ UTRs, with increased
density upstream of the cleavage and polyadenylation site (PAS)
(Fig. 3A). Consistent with the established activity of CELF1 in
binding mRNAs and recruiting cytoplasmic deadenylases (Vla-
sova-St Louis et al. 2013), binding density increased close to the
PAS on the upstream side and fell to background levels just down-
stream from the PAS site in heart, muscle, andmyoblast. Increased
phylogenetic conservation was observed for 3′ UTRs containing
CELF1 CLIP clusters, relative to 3′ UTRs with a similar length
and expression level, suggesting that these mRNAs are enriched
for conserved functionalmotifs or structures (Fig. 3B). GO analysis
of 3′ UTR binding targets of CELF1 revealed enrichment of pro-
teins related to muscle structures, such as M band and I band,
and factors involved in vesicle and protein transport in both heart
and muscle (Supplemental Table S5).
Analyzing gene expression globally, we observed that mean
expression of CELF1-bound mRNAs decreased substantially at
7 d after CELF1 induction relative to genes not bound by CELF1
(Supplemental Table S6). For example, the Clcn1 mRNA, which
had prominent CELF1 binding clusters in its 3′ UTR, decreased
in expression 50%–70% from its initial level 7 d afterCELF1 induc-
tion, in both muscle (Fig. 3C) and heart (Supplemental Table S6).
Furthermore, the average magnitude of target down-regulation
increased monotonically with the density of CLIP clusters in the
3′ UTR, reaching 1.4-fold and twofold in heart andmuscle, respec-
tively, for messages with four or more CLIP clusters per kb of
3′ UTR (Fig. 3D). The consistent association between binding
and down-regulation and the “dose-response” effect observed in
Figure 3D both support a direct role for CELF1 in target mRNA
repression.
Figure 3. CELF1 binds to 3′ UTRs and regulates message stability in a dose-dependent fashion. (A) Mean CELF1 CLIP density at positions along 3′ UTRs in
heart, muscle, andmyoblasts. (B) Mean conservation in sets of 3′ UTRs with and without CELF1 CLIP clusters with similar expression levels and UTR lengths
(shading represents SEM). (C) Expression of Clcn1 in muscle based on RNA-seq (mean ± SD) at various times following CELF1 overexpression (bottom); CLIP
density in Clcn1 3′ UTR (top). (D)Mean log expression change followingCELF1 induction (7 d over control) for transcripts grouped by number of CELF1 CLIP
clusters in their 3′ UTRs. Transcripts with greater CLIP cluster density are down-regulated more strongly in heart and muscle (number of genes in each cat-
egory listed above). Significance was assessed by rank-sum test, where each CLIP cluster bin was compared to the zero CLIP cluster bin. See also
Supplemental Table S6.
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We expected similar levels of CELF1-mediated target repres-
sion to occur in heart andmuscle, given that the level ofCELF1 in-
ductionwas similar in both tissues (Supplemental Fig. S1; Koshelev
et al. 2010; Ward et al. 2010). However, the magnitude of target
down-regulation in the heart was consistently only about half of
that observed in muscle for messages with similar CLIP density.
This difference might be related to a pattern we observed in which
targets of miRNAs were derepressed in the heart following CELF1
induction (Supplemental Fig. S5).
CELF1 binding to alternative 3′ UTRs is associated
with isoform-specific repression
Many mammalian genes end with more than one PAS, yielding
“tandem UTR” isoforms, differing in the length of their 3′ UTRs.
We observed many instances of altered 3′ UTR isoform abundance
following CELF1 induction in the heart and muscle. For example,
the Cnih4 gene, a member of the cornichon family AMPA receptor
auxiliary proteins involved in the selective transport and matura-
tion of TGF-alpha family proteins, contains multiple tandem al-
ternative PASs that are used in these tissues. CELF1 CLIP clusters
are located in the extension region of the Cnih4 3′ UTR between
the two PASs (Fig. 4A). The relative abundance of the longer iso-
form relative to total Cnih4 mRNAs was ∼85% in adult heart and
∼75% in muscle but decreased monotonically in both tissues
following CELF1 induction to ∼30% and 40%, respectively (Fig.
4A), consistent with CELF1-mediated down-regulation of the lon-
ger isoform. Our genome-wide analysis revealed that 57 tandem
UTR events contained at least three CELF1 clusters in the exten-
sion region and zero clusters within the core (shared) region; of
these, ∼75% followed the pattern of Cnih4, exhibiting decreased
abundance of the longer isoform relative to the shorter isoform fol-
lowing CELF1 induction. Across other combinations of binding
sites, a consistent trend was observed with higher relative abun-
dance of CELF1 clusters in extension versus core regions associated
with greater relative decline in distal isoform expression (Fig. 4B).
Changes in tandem UTR expression associated with CELF1
binding could, in principle, result from regulation of cleavage
and polyadenylation to produce less of the distal PAS isoform or
by differential regulation of the stabilities of the isoforms. If regu-
lation occurs by the latter mechanism, overall gene expression
should decrease following CELF1 induction in proportion to the
extent of binding in the core and extension regions, with binding
in the core exerting a stronger effect, since the core region is shared
by both isoforms. Our analysis of expression changes of tandem
UTR genes revealed exactly this: Following induction, gene expres-
sion decreased with the number of CELF1 CLIP clusters in either
region (Fig. 4C). By using a linear model, we compared the magni-
tude of down-regulation associated with extension and core sites
and found that sites in the core were associated with down-regula-
tion of mRNA expression by 6.9 ± 2.7% (95% CI) per site, and sites
in the extension were associated with 2.7 ± 2.5% down-regulation.
Because of their presence in both long and short isoforms, core
sites are expected to exert stronger effects on overall gene expres-
sion than are sites in the extension, as observed. Therefore, the
effects of CELF1 on tandem UTR isoform expression can be ex-
plained based on the factor’s known ability to destabilize mRNAs
via recruitment of deadenylases without needing to invoke a po-
tential activity in regulating cleavage and polyadenylation.
In thousands of othermammalian genes, a combination of al-
ternative splicing and alternative PAS usage gives rise to alternative
last exons (ALEs) (Fig. 4D). The distinct 3′ UTRs of ALEs provide
natural reporters of 3′ UTR functions, since they generally have lit-
tle or no effect on theORF. Formore than 1000 genes, we observed
amonotonic change in the relative expression of ALE isoforms fol-
lowing CELF1 induction in muscle. The ALE isoform exhibiting
greater CELF1 binding tended to be down-regulated, and the
magnitude of this bias increased as the difference in the number
of sites increased (Fig. 4D). A similar bias was observed in ALE pairs
lacking CELF1 binding within 500 nt of each alternative splice site
(Supplemental Fig. S6), suggesting that changes in ALE abundance
do not commonly result from regulation of splicing by CELF1.
Furthermore, as was observed for tandem UTRs, increased CELF1
binding was associated with increased mRNA down-regulation
(Fig. 4E), with an average magnitude of 5.9 ± 1% (95% CI) per
CLIP cluster, consistent with mRNA destabilizing activity. Togeth-
er, the consistent pattern of down-regulation of mRNAs (Fig. 3D)
and of specific mRNA isoforms (Fig. 4B–E) associated with CELF1
binding to 3′ UTRs provides evidence of widespread direct effects
of binding on mRNA expression and identifies numerous instanc-
es of gene- and isoform-specific regulation.
Evidence for CELF1-mediated regulation of alternative
3′ UTR isoforms in development
The dramatic changes in CELF1 levels that occur during heart de-
velopment led us to ask whether these 3′ UTR isoforms are often
developmentally regulated. By comparing changes in 3′ UTR iso-
form abundance during heart development to changes following
CELF1 induction in heart, we observed a strong negative correla-
tion (RSp =−0.52) (Fig. 4F). Therefore, as observed at the level of
splicing, CELF1 induction tends to reverse isoform changes that
occur during normal heart development. This negative correlation
held whether analyzing CELF1 induction in heart or skeletal mus-
cle and whether analyzing tandem UTRs or ALEs (Fig. 4G). The
hundreds of 3′ UTR isoforms involved in these patterns suggest
that developmental reductions in CELF1 activity underlie a sub-
stantial fraction of 3′ UTR isoform changes that occur during heart
development.
Antagonistic regulation of mRNA expression by CELF
and MBNL proteins
In addition to their nuclear functions in RNA splicing, MBNL pro-
teins also exert cytoplasmic functions, targeting 3′ UTR-bound
mRNAs for localization to membrane destinations and promoting
translation of targeted messages (Adereth et al. 2005; Wang et al.
2012). To ask whether this function might be related to mRNA re-
pression by CELF proteins, we compared CELF1 and MBNL1 3′
UTR binding targets. We observed more than 1000 3′ UTRs bound
by bothCELF1 andMBNL1 (with at least twoCLIP clusters for each
factor), three times as many as expected by chance (P < 1 × 10−48,
Fisher’s exact test) (Fig. 5A; for CLIP clusters, see Supplemental
Table S7). Given that gene expression level impacts the statistical
power to detect CLIP binding, we assessed the fold enrichment
of cobinding relative to independence in sets of genes binned by
expression level, and observed as well as expected numbers of
shared targets are shown in Figure 5A. These genes were enriched
for a number of GO categories, including categories related to cy-
toskeleton, such as “actin cytoskeleton organization,” and to de-
velopment, such as “mesoderm formation,” “patterning of blood
vessels,” “ventricular septum development,” and other categories
(Supplemental Table S8), suggesting important developmental
functions. These observations led us to explore whether CELF
Antagonistic mRNA regulation by CELF and MBNL
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Figure 4. CELF1 regulates abundance of bound alternative 3′ UTRs, reversing developmental changes. (A) CELF1 CLIP-seq density in 3′ UTR of the Cnih4
gene, which has two alternative PASs whose relative abundance changes following CELF1 overexpression and during heart development. (B) CELF1 regu-
lates tandem 3′ UTR events in a manner that is dependent on the number of binding sites in the core and/or extension region of the 3′ UTR. The heatmap
shows the fraction of tandem UTR events biased toward usage of the proximal PAS following CELF1 overexpression in muscle for events grouped by the
number of CLIP clusters in the proximal or distal region of the 3′ UTR (MZ > 1.6). Significance was assessed by binomial test, assuming equal likelihood
for usage of long or short isoforms. (C) Messages with regulated tandem 3′ UTR events tend to be down-regulated following CELF1 induction. The heatmap
shows themean expression change following CELF1 induction inmuscle for genes harboring events grouped by the number of CLIP clusters in the proximal
or distal region of the 3′ UTR. Significance was assessed by rank-sum test, where each bin was compared to the bin with zero CLIP clusters. (D) CELF1 reg-
ulates ALE expression in a manner that is dependent on the number of binding sites in the competing 3′ UTRs. The fraction of ALEs that is significantly
repressed following CELF1 overexpression in muscle, grouped by density in repressed 3′ UTR minus density in enhanced 3′ UTR (MZ > 1.5). Significance
was assessed by binomial test, assuming equal likelihood for usage of each ALE isoform. (E) Messages with CELF1 binding within ALEs tend to be
down-regulated following CELF1 induction. (Bar plot) Mean expression change following CELF1 induction in muscle for genes with varying numbers of
CLIP clusters within ALEs. Significance was assessed by rank-sum test relative to genes with no CLIP clusters. (F) Changes in ALE usage during heart devel-
opment inversely correlate with those that occur in response to CELF1 overexpression in heart. Correlation coefficients shown for events meeting a min-
imum Z-score threshold (heart development, 1.4; CELF1 OE, 1.8), as in Figure 1B. (G) Spearman correlation coefficients and significance of correlation
are displayed in heatmap format for change in ALE usage (right) or change in tandem3′ UTR usage (left) for pairwise comparisons of isoform changes during
heart development, CELF1 overexpression in heart, and CELF1 overexpression in muscle. See also Supplemental Figure S6.
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and MBNL might exert antagonistic, or
synergistic, effects on mRNA levels.
To assess possible functional rela-
tionships between the effects of CELF
andMBNL proteins on expression, we as-
sessed gene expression changes for sets of
genes grouped by extent of CELF1 and
MBNL1 binding. Expression changes fol-
lowing CELF1 induction exhibited a
strong dependence on the ratio of
CELF1 to MBNL1 binding sites: Greater
CELF1 binding was associated with
strong (up to approximately twofold) av-
erage down-regulation, messages with
similar numbers of CELF1 and MBNL1
clusters exhibited little change, and
those with greater MBNL1 binding
showed increased expression (Fig. 5B).
These data suggest that MBNL binding
can protect amessage fromCELF-mediat-
ed repression. The highly consistent pat-
tern in which each additional CELF
binding site conferred reduced expres-
sion, while each additional MBNL bind-
ing site conferred increased expression,
suggests that MBNL1 and CELF1 com-
pete for cobound mRNAs to target them
for different fates. The set of mRNAs
that (1) were down-regulated upon
CELF1 induction; (2) are bound by both
CELF1 and MBNL1; and (3) changed
their localization upon Mbnl depletion
in the expected direction (away from
membrane and toward the insoluble
compartment, based on our previous
study) (Wang et al. 2012) included Cpe,
Igfbp5, Kcnj2, and Sobp (see Discussion).
Within the set ofmRNAsnot detect-
ably bound by CELF1, the up-regulation
of mRNAs bound more strongly by
MBNL1 relative to less-bound messages
was unexpected. One possible explana-
tion is that this signal derives from
CELF1CLIP false negatives, i.e., messages
that are bound by CELF1 but that failed
to crosslink efficiently (or failed to be re-
covered in our CLIP-seq data for other
technical reasons). Another possibility
is that CELF proteins may exert a general
nonspecific or low-specificity, mRNA de-
cay-promoting activity at high levels and
that MBNL binding protects against this
effect as well as the effects of specific
CELF1 binding.
To further explore the relationship
between CELF1 and MBNL1 proteins,
we analyzed the relative locations of
CELF1 and MBNL1 binding sites in 3′
UTRs. We found that sites bound by
CELF1 and MBNL1 tended to cluster to-
gether more than expected, relative to
randomly placed clusters (P < 1.8 × 10−55
Figure 5. CELF1 andMBNL1 bind in close proximity to the same 3′ UTRs and exert opposing effects on
mRNA stability. (A) Venn diagram showing the expected and observed overlap between CELF1 and
MBNL1 3′ UTR targets (CELF1 data from muscle, MBNL1 data from myoblasts). The observed overlap
is approximately three times larger than expected (analysis controlled for gene expression) and signifi-
cant by Fisher’s exact test. (B) Expression change following CELF1 induction inmuscle (7 d versus control)
for transcripts grouped by number of MBNL1 and CELF1 CLIP clusters in the 3′ UTR. CLIP clusters for
MBNL1 and CELF1 were derived from myoblast and muscle, respectively. (C) The probability density
function (PDF) of the distribution of distances between CELF1 CLIP clusters in muscle and MBNL1
CLIP clusters in myoblasts, in 3′ UTRs with binding for both proteins. Distances for true binding sites
are shown in blue; for randomly placed binding sites, in black. Statistical significance was assessed by
modified KS test, and the distribution of distances in shuffled controls is shown in gray. (D) Expression
change following CELF1 induction in muscle (7 d versus control) for transcripts with exactly one
MBNL1 CLIP cluster and exactly one CELF1 CLIP cluster. Genes were grouped according to whether
the distance between motifs is less than or greater than 50 base pairs (bp). Significance was assessed
by rank-sum test. (E) Expression change during heart development (adult versus E17) for transcripts
with varying numbers of MBNL1 and CELF1 CLIP clusters. Genes were grouped according to the relative
abundance ofMBNL1 andCELF1 CLIP clusters and by the presence/absence of a proximalMBNL1/CELF1
binding pair. Only transcripts with gene expression MZ scores >0.5 were included in this analysis, and
significance was assessed by KS test. See also Supplemental Figures S7 and S8 and Supplemental
Tables S7 and S8. (F) MBNL1 presence does not affect in vitro binding of CELF1 to RNA. 130-nM tagged
CELF1 and 250-nM MBNL1 were equilibrated in vitro with random RNA 40mers in an RNA Bind-n-Seq
experiment. The tagged CELF1 was pulled down, bound 40mers were eluted and sequenced, and
RBNS R of each 6mer was calculated as the frequency in the pulldown library divided by the frequency
in the input library. 6mers were classified as weak, medium, or strong (RBNS R Z-score between 1–2,
2–3, or >3, respectively), CELF1-binding, MBNL-binding, or none of the above (“Other”) using the
data from Lambert et al. 2014 and color-coded as indicated.
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by Kolmogorov-Smirnov [KS] test) (Fig. 5C). This proximity effect
remained highly significant when performing additional analyses
that preserved the locations of CELF1 and MBNL1 binding sites
but permuted protein identity, a treatment that controls for varia-
tions in local base composition and accessibility along mRNAs
(Supplemental Fig. S7A).
To ask whether functional antagonism between MBNL1 and
CELF1 might depend on binding site proximity, we examined the
effects of CELF1 induction on messages with proximal (≤50 nt) or
distal (>50 nt) pairs of CELF1 and MBNL1 binding sites. The pres-
ence of a distal MBNL1 site was sufficient to abrogate the repres-
sion normally associated with presence of a CELF1 site, but
presence of a proximal MBNL1 site lacked such a protective effect
(Fig. 5D). These trends extended to messages containing multiple
CELF1 sites. Comparing sets ofmRNAswith the same distributions
of CELF1 site counts and with exactly one MBNL1 site, those with
a greater number of proximal CELF1/MBNL1 pairs were more
strongly down-regulated following CELF1 induction (Supplemen-
tal Fig. S5B). This phenomenon of “local inhibition” of MBNL1’s
activity by CELF1 suggests that CELF1 can bind to messages
when MBNL1 is bound nearby, and is readily explicable by either
of two models: (1) “local inhibition of binding,” in which inhibi-
tion results simply from CELF1 inhibiting nearby binding of
MBNL1, either directly through steric hindrance or indirectly via
effects on local RNA structure; or (2) “local inhibition of function,”
in which occupancy of CELF1 binding sites proximal to bound
MBNL1 antagonizes the localization/stabilization function con-
ferred by MBNL1 without affecting MBNL1’s binding.
Under either model, mRNAs containing a proximal pair of
MBNL and CELF sites are expected to be more responsive to de-
velopmental changes in CELF and MBNL levels than messages
containing distal pairs of sites. To explore this idea, we assessed
developmental changes in expression of mRNAs grouped by bind-
ing site count and presence of proximal or distal CELF/MBNL site
pairs (Fig. 5E). Overall, we observed moderate derepression in pro-
portion to the number of CELF sites present and observed repres-
sion when MBNL sites exceeded CELF sites. This pattern reverses
the pattern observed in Figure 4B, as expected given the down-reg-
ulation of CELF1 during heart development. Moreover, messages
containing proximal CELF/MBNL pairs were derepressed more
strongly than those containing exclusively distal pairs, consistent
with the local inhibition phenomenon observed in Figure 5D.
Together, these data indicate that the regulatory rules that govern
CELF1 function in heart development are similar to those observed
in the transgenic mouse model.
No evidence for direct antagonism of binding for CELF
and MBNL proteins
To help distinguish between the “local inhibition of binding” and
“local inhibition of function” models introduced above, we per-
formed a variant of our RNA Bind-n-Seq (RBNS) assay (Lambert
et al. 2014), in which recombinant, tagged CELF1 protein was in-
cubatedwith a pool of randomRNA oligonucleotides (of length 40
nt), in the absence ofMBNL1 or in the presence of varying concen-
trations of recombinant MBNL1 protein. This experiment can be
thought of as mimicking the effects of developmental induction
of MBNL1 on CELF1’s interaction with RNA. Following pulldown
of CELF1 using the affinity tag, bound RNA was eluted and used
to prepare libraries for high-throughput sequencing (Methods).
The calculation of motif enrichment (called RBNS R-values) in
the CELF1 pulldown libraries relative to a control library prepared
from input RNA enables assessment of sequence-specific RNA
affinity.
By analyzing all RNA 6mers, we observed a strong preference
for GU- and UGU-containing motifs such as UGUUGU in all pull-
down libraries, consistent with previous studies (Faustino and
Cooper 2005;Marquis et al. 2006; Lambert et al. 2014). By compar-
ing data obtained with relatively highMBNL1 concentration (e.g.,
250 nM, a concentration at which MBNL1 exhibits strong se-
quence-specific binding in this assay) to 0 MBNL concentration,
we observed no effect of the presence ofMBNL1 protein on the ab-
solute or relative affinity of CELF1 for different RNA motifs (Fig.
5F), nor any effect of the presence ofMBNL1motifs in the oligonu-
cleotide. These observationswere consistent across a range of addi-
tionalMBNL1 concentrations, from 64 nM to 1 μM (Supplemental
Fig. S8). This result was not entirely unexpected, as CELFs and
MBNLs have distinct sequence specificities, with CELF1 favoring
GU- and UGU-containing motifs (Faustino and Cooper 2005;
Marquis et al. 2006; Lambert et al. 2014), andMBNL1 favoringmo-
tifs containing UGC and/or GCU (Goers et al. 2010; Lambert et al.
2014). These data suggest that binding of these two proteins to
RNA exhibits neither synergism nor antagonism, instead occur-
ring independently. Of course, the usual caveats regarding the ex-
perimental setup and presence of an affinity tag on CELF1 apply,
and the in vivo situation might be different. This conclusion pro-
vides no support for local inhibition of binding but is consistent
with the local inhibition of function model.
Discussion
The relationship between CELF and MBNL proteins is important
both in the development and context of neuromuscular disease,
particularly DM. Throughout mouse heart development, CELF
protein levels decrease and MBNL levels increase (Kalsotra et al.
2008); in DM, MBNL proteins are sequestered by expanded CUG
or CCUG repeats, and CELF proteins are stabilized via hyperphos-
phorylation by PKC and derepressed as a result of reduced miRNA
expression (Timchenko et al. 2004; Kuyumcu-Martinez et al. 2007;
Kalsotra et al. 2010). The nature of the relationship between these
RBPs in normal physiology and development has been a long-
standing question in the field.
It has recently been established that many genes shift toward
greater expression of longer 3′ UTR isoforms during differentiation
of muscle cells and likely other cell types (Ji et al. 2009). We ob-
served a strong pattern of antagonistic regulation of mRNA levels
by CELF and MBNLs associated with binding to 3′ UTR regions.
It is known that CELF1 can recruit deadenylases to 3′ UTRs and
destabilize mRNAs (Vlasova et al. 2008), and recently we uncov-
ered a global role for MBNLs in localizing mRNAs to membrane
destinations for localized translation (Wang et al. 2012). These ob-
servations suggest a model in which MBNL and CELF proteins
specify different cellular outcomes for mRNAs and compete with
one another to determine the localization/stabilization or destabi-
lization of specific mRNAs that contain binding motifs for both
factors (Fig. 6A). Changes in localization often impact mRNA
stability (Walters and Parker 2014). Our data, e.g., the pattern
shown in Figure 5B, can be most simply explained if messages
tend to have a basal decay rate in the cytoplasm, which is generally
accelerated by CELF1 induction and specifically enhanced by di-
rect CELF1 binding, but have a lower decay rate when localized
to the membrane compartment. Under this model, the localiza-
tions and half-lives of more than 1000 messages bound by both
Wang et al.
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factors are determined by the outcome of a competition between
the activities of MBNL and CELF proteins.
Down-regulation of the CLCN1 gene, which encodes the ma-
jor voltage-gated chloride channel that controls the membrane
excitability of skeletal muscle, causes the myotonia that is charac-
teristic of DM (Charlet et al. 2002; Mankodi et al. 2002). This
down-regulation is thought to result primarily from aberrant in-
clusion of exon 7a, due to loss ofMBNL1 activity, which produces
a nonfunctional CLCN1 mRNA (Wheeler et al. 2007). Here, we
showed that Clcn1 mRNA levels decreased monotonically follow-
ing CELF1 induction in both muscle and heart and that CELF1
binds to the Clcn1 3′ UTR (Fig. 3C). These observations suggest
that CELF1 may down-regulate the stability of Clcn1mRNA, inde-
pendently of splicing regulation. Therefore, the up-regulation of
CELF activity that often accompanies MBNL sequestration in
DM skeletal muscle may destabilize the CLCN1mRNA and exacer-
bate myotonia symptoms.
Other messages bound by both factors whose expression re-
sponded to CELF1 induction and whose localization changed in
response toMbnl1 depletion (Results) included Kcnj2, a cardiac in-
ward rectifier potassium channel whose mutation is associated
with a syndrome that involves cardiac arrhythmia (Andelfinger
et al. 2002), and the sine oculis binding protein homolog Sobp,
mutations of which have been linked to intellectual disability
(Birk et al. 2010). Other messages with this pattern of binding
and localization included Cpe, which is involved in insulin pro-
cessing, and Igfbp5, which regulates insulin-responsive growth fac-
tor. Thus, genes that encode competing mRNA targets of CELFs
and MBNLs may contribute to symptoms such as cardiac arrhyth-
mia, mental retardation, and insulin resistance, which are ob-
served in DM.
The distance between CELF and MBNL sites on a message ap-
pears to play an important role in the outcome of competition be-
tween these factors: Close spacing of CELF1 sites near MBNL sites
(less than ∼50 nt apart) appears to over-
ride the protective effect normally con-
ferred by MBNL1 binding (Figs. 5D, 6B),
either by inhibition of binding or of ac-
tivity. Our in vitro binding data (Fig.
5F) did not detect evidence of a coopera-
tive or antagonistic relationship between
binding of CELF1 and MBNL1, suggest-
ing that antagonism occurs at the func-
tional level. For example, CELF binding
may inhibit the recruitment or activity
ofMBNL-dependent complexes involved
in mRNA localization or stabilization.
Functional antagonism between RBPs
that bind to the same mRNAs is well
known; e.g., PTB can repress U1 snRNP’s
ability to promote spliceosome forma-
tion without inhibiting its binding to
the 5′ splice site (Izquierdo et al. 2005;
Sharma et al. 2005), and SRRM4 (also
known as NSR100) can overcome the re-
pressive effects of PTBP1 without gener-
ally interfering with its binding (Raj
et al. 2014). The functional antagonism
between MBNL and CELF proteins un-
covered here is likely to contribute to
the robustness of developmental chang-
es in mRNA stability and localization,
particularly for mRNAs bound by both factors (Fig. 5E). These
mRNAs may be particularly susceptible to misregulation in DM,
perhaps contributing to pathogenesis.
We identified several dozen exons exhibiting antagonistic
splicing regulation,manyof which are developmentally regulated.
These exons tend to preserve the reading frame and to reside in
genes affecting functions involved in development and cell differ-
entiation (see Results). Human homologs of this set of antagonis-
tically regulated exonsmay bemisregulated inDM to a particularly
strong extent, as increased levels of CELF proteins would exacer-
bate splicing changes that result from MBNL sequestration. The
hypothesis that CELF binding to exons tends to repress splicing,
suggested by genome-wide analyses, was confirmed in a splicing
reporter system, establishing a rule to predict CELF-dependent
splicing regulation.
CELF1 function intersects with RNA processing in a different
way in its impact on the stability of alternative mRNA isoforms
that differ in their 3′ UTRs. We observed a large set of genes with
developmentally regulated ALEs and tandem UTR isoforms that
differentially respond to CELF induction (Fig. 4). Regulation of
some of these isoforms by CELF1 may impact encoded protein
functions by changing the abundance of protein isoforms dif-
fering in their C termini, while regulation of others may alter
mRNA localization or translation or other UTR-dependent proper-
ties during development and other physiological situations in
which CELF activity changes.
Methods
Heart inducible CELF2 mouse
N-terminal FLAG-tagged human CELF2 was expressed from the
transgene previously used for CELF1 (Koshelev et al. 2010).
TRECUGBP2 transgenic mice were generated by standard
Figure 6. Functional antagonism model of effects of CELF and MBNL proteins on mRNA fates. (A)
Summary of known nonsplicing activities: CELF1 binding to 3′ UTRs promotes mRNA deadenylation
and decay (Vlasova and Bohjanen 2008), while MBNL1 binding to 3′ UTRs promotes localization to
membrane compartments (Wang et al. 2012). (B) Binding of both proteins to the samemRNA is expect-
ed to result in a functional tug-of-war. For mRNAs containing distal MBNL and CELF binding sites, MBNL
promotes targeting of the mRNA for localization and stabilization, while CELF binding promotes decay.
For mRNAs containing proximal MBNL and CELF binding sites, CELF1 may directly antagonize MBNL1
function, e.g., by preventing recruitment of complexes associated with localization or inhibiting their
function.
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techniques and maintained on an FVB background. All reported
TRECUGBP2/MHCrtTA bitransgenic mice were the F1 progeny
from TRECUGBP2 ×MHCrtTA (FVB/N-Tg(Myh6-rtTA)1Jam) mat-
ings. TRECUGBP2/MHCrtTA bitransgenic mice induced using
doxycycline did not show evidence of ECG, echocardiography ab-
normalities, or abnormal heart size ormorphology after 8 wk of in-
duced expression of CELF2.
RNA-seq library preparation and sequencing
CELF1 andCELF2were induced in the heart andmuscle by feeding
mice 2 g/kg doxycycline for 12, 24, 72 h, or 7 d in the relevant
transgenic animal. For CELF1 induction in the heart, mice with
myosin heavy chain, promoter-driven, reverse tetracycline trans-
activator (rtTA) and Tet-inducible, N-terminal FLAG-tagged hu-
man CELF1 LYLQ isoform were used (data are provided under
GEO accession GSE56185) (Giudice et al. 2014). For CELF2 induc-
tion in the heart, mice with the myosin heavy chain promoter-
driven rtTA and Tet-inducible human CELF2 were used. Hearts
were harvested, atria removed, and ventricles frozen in liquid ni-
trogen. For CELF1 induction in muscle, mice with the rat myosin
light chain 1/3 promoter/enhancer driving rtTA and Tet-inducible,
N-terminal FLAG-tagged human CELF1 LYLQ isoform were used.
The left and right gastrocnemius were isolated and frozen in liquid
nitrogen. Control experiments for all time courses used mice with
rtTA cassettes but lacking the Tet-inducible CELF cassettes; control
mice were fed 2 g/kg doxycycline for 72 h before tissue harvest.
Total RNA was isolated in all cases using TRIzol (Invitrogen), fol-
lowed by RNeasy column with DNase treatment (Qiagen). Poly
(A)+ RNA was prepared using Oligo dT dynabeads (Invitrogen)
and prepared for paired-end RNA-seq (36–40 nt on Illumina GAII).
CLIP-seq library preparation and sequencing
CLIPwas performed using 254-nmUV irradiation as previously de-
scribed (Wang et al. 2009b), using heart tissue or muscle tissue of
16-wk-old mice or cultured C2C12 mouse myoblasts. Tissue was
ground to a powder using a liquid nitrogen–cooledmortar and pes-
tle prior to UV irradiation. The dry powder was placed into a 10-
cm2 tissue culture dish, sitting on ice, and crosslinked 3 × 400
mJ/cm2. In between each round of cross-linking, the dish was
shaken from side to side to redistribute the tissue powder and pro-
vide maximum opportunity for all tissue particles to be cross-
linked. The tissue was then lysed in RIPA buffer (50 mM Tris-HCl
at pH 7.4, 150 mM NaCl, 0.1% sodium deoxycholate, 1% NP-40,
0.5% SDS). The lysate was treated with DNase and RNase If (NEB)
for 10 min at 37° C, with dilutions of 1:10,000 and 1:50,000
providing optimal RNA fragment lengths for downstream purifica-
tion. Immunoprecipitationwas performed using the 3B1 antibody
clone against CELF1 (Millipore) and protein A beads (Invitrogen).
The beads were washed twice with RIPA and twice with RIPA con-
taining 1 M NaCl. The 3′ adapter was preadenylated with ImpA
(Hafner et al. 2008) and ligated while the RNA–protein complexes
were on beads using T4 RNA ligase (Rnl2 truncation) in the ab-
sence of ATP (NEB). The complexes were run on SDS-PAGE gel,
transferred to nitrocellulose, and isolated frommembrane as previ-
ously described (Wang et al. 2009b). Further details are provided in
the Supplemental Material.
RNA-seq and CLIP-seq read mapping, gene expression estimation
All readmapping was performed using Bowtie/TopHat (Langmead
et al. 2009; Trapnell et al. 2009), mapping to mm9. Only uniquely
mapping reads were used. CLIP reads were collapsed to remove
identical sequences; adapter sequences were removed; and pro-
cessed reads were then mapped separately for each CLIP read
length. To estimate gene expression levels, the number of reads
mapping to each kilobase of constitutive coding sequence of
RefSeq/Locuslink genes was counted and divided by the number
of reads (in millions) mapping uniquely to nonribosomal and
nonmitochondrial sequence to obtain RPKM values. For purposes
of the analyses performed in Figure 4E, gene expression values in
the heart development time course were normalized as previously
described (Robinson and Oshlack 2010), using parametersM = 0.3
and A = 0.2.
Estimation of isoform frequencies, calculation of MZ score
MISO (version 0.4.8) (Katz et al. 2010)was used to estimate isoform
frequencies for splicing events and alternative 3′ UTR events, using
a minimum of 20 reads per event and the parameters of burn
_in=500, lag=10, num_iters=5000, and num_chains=6. To iden
tify splicing events that change monotonically over time, we or-
dered samples chronologically, and for each event compared all
pairs of samples from different time points, tallying the number
of comparisons representing significant increase or significant
decrease in Ψ (at BF > 5). We calculated a quantity called δ, the
number of significant positive ΔΨ values (increases over time)
minus the number of significant negative ΔΨ values. To assess stat-
istical significance, we recalculated δ after randomly permuting the
sample labels. Repeating this process 100 times, we generated a
null distribution and derived the “monotonicity Z-score” (MZ =
(δ− μ)/σ), where μ and σ are the mean and standard deviation of
the null distribution, respectively.
Analysis of antagonistically regulated splicing events
Splicing events regulated in response to each perturbation (CELF
overexpression,Mbnl1 KO, or heart development) were enumerat-
ed, and the number of events regulated among each pair of pertur-
bations was counted (this was the “observed” overlap) (Fig. 1G,H).
To compute the “expected” overlap, we assumed independence;
e.g., the fraction of events regulated in both perturbations equals
the fraction of events regulated in the first perturbationmultiplied
by the fraction of events regulated in the second perturba-
tion. Significance of the bias in direction of regulation (Fig. 1H)
was assessed by binomial test, assuming a null hypothesis frequen-
cy of 0.5.
Analysis of CLIP clusters and correlation across the transcriptome
Analysis of CLIP data was performed as described in the
Supplemental Material (Fig. 2B,C,E; Supplemental Fig. S3B,C).
Conservation analysis for cassette exons and 3′ UTRs
Conservation (30-way phastCons, UCSC Genome Browser) of cas-
sette exons with CLIP clusters within 1 kb of each splice site or
within the exon itself was compared to a control set of cassette ex-
ons found in similarly expressed genes (Figs. 2D, 3B). Conservation
(30-way phastCons) of 3′ UTRs with CLIP clusters <1 kb upstream
of and <500 bases downstream from the constitutive transcript
ends was assessed and compared to a control set of 3′ UTRs with
similar length, in similarly expressed genes. For these analyses,
CLIP clusters and gene expression values from heart were used.
Analysis of gene expression changes as a function of CELF CLIP
clusters and/or miRNA seed matches
Genes were grouped by the number of CELF CLIP clusters found in
3′ UTRs (Fig. 3D) or miRNA seed matches (Supplemental Fig. S5A),
and the mean log2(fold-change) in expression level in each group
was computed, relative to genes with no CLIP clusters or miRNA
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seeds, respectively (Fig. 3D; Supplemental Fig. S5A). Significance
was assessed by rank-sum test. The abundance of miRNAs in heart
(Supplemental Fig. S5B) was derived from Li et al. (2013).
Analysis of binding targets shared by CELF1 and MBNL1
Genes were binned by expression level in mouse myoblast (Wang
et al. 2012), andwithin eachbin, the number of geneswith 3′ UTRs
containing CELF1 CLIP clusters only, MBNL1 CLIP clusters only,
or clusters for both proteins was counted (“observed” number).
The “expected” number was computed by assuming indepen-
dence. The approximately threefold observed/expected value was
obtained by taking the mean observed/expected value across all
gene expression bins. In Figure 5A, CLIP data for CELF1 were de-
rived from muscle; data for MBNL1 were derived from myoblasts.
Analysis of CELF1 and MBNL1 binding locations within 3′ UTRs
To precisely assess the distance between CELF1 and MBNL1 bind-
ing locations within 3′ UTRs, we searched for known CELF1 and
MBNL1 binding motifs within each CLIP cluster for each protein
(Fig. 5C–E; Supplemental Fig. S7A,B). The motifs were derived
fromBind-n-Seq data (Lambert et al. 2014). ForMBNL1, themotifs
were GCTT, CGCT, TGCT, GCGC, CCGC, CTGC, GCTA, ACGC,
CGCA, AGCT, TTGC, and CAGC. For CELF1, the motifs were
TGTT, ATGT, TTGT, TGTC, GTGT, TGTA, GTTT, TGTG, GTCT,
and TTTT. If none of these motifs was found within the cluster,
the binding location was estimated to be the center of the CLIP
cluster. The closest distance between each CELF1 andMBNL1mo-
tif derived from its respective cluster was recorded and compared
with randomly assigned clusters (Fig. 5C) or clusters whose identi-
ty was shuffled (Supplemental Fig. S7A). Tests for significant differ-
ences in Figure 5C and Supplemental Figure S7A were performed
by modified KS test, where cumulative distributions were visually
inspected to confirm a true shift in median values.
Analysis of alternative 3′ UTR isoforms
The abundance of alternative 3′ UTR isoforms by MISO was per-
formed in “multi-isoform” mode (Fig. 4B–E; Supplemental Fig.
S6). However, analysis was restricted to those events with exactly
two isoforms whose regulation is significant and monotonic (BF
> 5,MZ > 1.6 for tandemUTRs,MZ > 1.5 for ALEs). To assess chang-
es in gene expression, genes were binned by the number of CELF1
CLIP clusters in the “core” or “extension” regions (Fig. 4B) or in
both ALEs (Fig. 4E), and the mean expression change following
CELF1 induction in each bin was compared to the mean
expression change in the binwith zero CELF1CLIP clusters. Signif-
icance was assessed by rank-sum test. To estimate the “potency” of
each CLIP cluster, we used a linear model; for tandem UTRs, we
considered a linear model in which log(expression change) is pro-
portional to the number of core sites × potency of core site + num-
ber of extension sites × potency of extension ×Ψextension. For ALEs,
we considered a model in which log(expression change) is propor-
tional to the number of sites in ALE1 × potency ×ΨALE1 + number
of sites in ALE2 × potency ×ΨALE2. In both cases, coefficients were
estimated by least squares regression.
Data access
The RNA-seq, CLIP-Seq, andRBNS sequencing data from this study
have been submitted to the NCBI Gene Expression Omnibus
(GEO; http://www.ncbi.nlm.nih.gov/geo/) under superseries ac-
cession number GSE61893.
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